These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26912302)

  • 1. Predictive Impact for Postoperative Recurrence of Preoperative Serum Krebs von den Lungen-6 Concentration in Pathologic Stage IA Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 May; 101(5):1903-8. PubMed ID: 26912302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
    Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
    Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
    Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
    Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1193-9. PubMed ID: 24667022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of clinical/pathological stage IA non-small-cell lung cancer showing partially solid or solid tumours on radiological exam.
    Uehara H; Matsuura Y; Nakao M; Mun M; Nakagawa K; Ishikawa Y; Okumura S
    Ann Thorac Cardiovasc Surg; 2015; 21(4):338-44. PubMed ID: 25740451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less.
    Kobayashi N; Toyooka S; Soh J; Ichimura K; Yanai H; Suehisa H; Ichihara S; Yamane M; Aoe M; Sano Y; Date H
    J Thorac Oncol; 2007 Sep; 2(9):808-12. PubMed ID: 17805057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
    Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
    J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
    Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.